
AutoFluorescent
Proteins and Fusion Vectors: AFPs
AFPs®
(AutoFluorescent Proteins) are optimized variants of the Aequorea victoria
green fluorescent protein. Modifications to the amino acid sequence of
wtGFP have generated AFPs® that are brighter, more efficient,
and have improved excitation and emission spectra. Our SuperGloGFP
(sgGFP) and SuperGloBFP (sgBFP)
are the brightest green and blue fluorescent proteins available today.
All of our
sgAFP vectors feature the following :
- AFPs®
designed with mutations that optimize protein folding and fluorophore
formation at 37°C.
- Codon-optimized
coding sequences to stabilize mRNA structure and enhance expression
without restricting host range.
- 'Kozak'
optimized initiation codons to encourage efficient translation.
sgGFP:
SuperGlo Green Fluorescent Protein
- Broadest
Stoke's shift of all green variants
- Single
enhanced excitation peak
sgGFP
is the only available GFP with a single enhanced excitation peak at 474
nm. All other popular variants have excitation peaks at or near 488 nm.
All of these variants fluoresce green at ~509 nm. sgGFP is
therefore the only GFP that has a Stoke's shift that exceeds the minimum
of 30 nm recommended for easy visualization and sensitive detection. sgGFP
can be readily detected on fluorimeters, fluorescent microscopes, and
by fluorescent cell sorters(FACS). sgGFP is also the best
partner for FRET with BFP.
Mutations:
F64L - improved solubility, and protein folding at 37°C;
more rapid and efficient fluorophore formation.
S65C - a single excitation peak at 474 nm.
I167T - enhanced excitation peak at 474 nm.
sgBFP:
SuperGlo Blue Fluorescent Protein
- Highest
quantum yield of blue variants
sgBFP
is the perfect partner for the GFP. It is brighter than other available
blue variants, and its spectral properties make it easy to distinguish
from GFP or YFP. sgBFP can be readily detected on fluorimeters,
fluorescent microscopes, and by fluorescent cell sorters. Furthermore,
the large overlap between the emission peak of sgBFP and
the excitation peak of sgGFP make them perfect partners for
FRET.
Mutations:
F64L - improved solubility, and protein folding
at 37°C; more rapid and efficient
fluorophore formation.
Y66H - a single excitation peak at 387 nm, and emission
at 450 nm.
V163A - improved solubility and protein folding.

Excitation
and Emission Peaks of AFPs®
| |
Excitation
Maxima (nm) |
Emission
Maxima(nm) |
| wtGFP |
395 (474) |
509 |
| S65T |
488 |
507 |
| sgGFP |
474 |
509 |
| sgBFP |
387 |
450 |
Stoke's shift
of 35 nm for improved detection
- clear
images
- increased
signal to noise ratio


AFP®
Fusion Vectors
| Feature |
Function |
| CMV promoter |
Drives high level
expression in mammalian cells. |
| SV40 neo
cassette |
Allows G418 selection
of transformed cells. |
| MCS |
Multiple Cloning
Site: 12 unique restriction sites on the N- or C-terminus of the AFPs
coding sequences. Available in all three reading frames, (1,2, or
3). |
| "Kozak"
optimized ATG |
Ensures efficient
translation in mammalian cells. |
| Peptide
linker |
Encourages independent
folding of linked protein moieties and favors bi-functional fusion
proteins. Composed of 4 to 6 Gly and/or Ala residues. |
| Fusion
site |
Most vectors contain
restriction sites that allow for the generation of N- or C-terminal
fusions, with or without an MCS. |
| Pgk promoter |
Murine phosphoglycerate
kinase promoter for long-term stable expression in ES cells or in
vivo. |
| Pol II
promoter |
Murine RNA polymerase
II promoter for long-term stable expression in vivo, or in ES cells. |
| sgGFP-neo |
An sgGFP-neo fusion
protein that confers both G418 resistance and green fluorescence so
that all cells surviving G418 are necessarily fluorescent. |
| T7 promoter |
Drives very high
level expression in bacteria that carry the T7. RNA polymerase gene. |
| pUC origin |
High copy number
plasmid origin. |
Storage
-20°C

Reporter
Vectors
These basic
reporter vectors can be used to generate fusion proteins between the C-terminus
or N-terminus of a target protein and the AFP®.
The pQBI-pgk
and pQBI-Pol II vectors can be used to generate stable transformants and
transgenic animals.
| Fusion Sites |
| Cat.
No. |
Vector |
AFP |
Promoter |
N
C MCS |
Comments |
Size |
| AFP2200 |
pQBI25f |
sgGFP |
CMV |
Y Y C-Term |
Alternative
C-terminus MCS |
20µg |
| AFP2100 |
pQBI50f |
sgBFP |
CMV |
Y Y C-Term |
Alternative
C-terminus MCS |
20µg |
| AFP2043 |
pQBI-pgk |
sgGFP-neo |
Pgk |
|
sgGFP-neo fusion protein |
20µg |
| AFP2044 |
pQBI-PolII |
sgGFP-neo |
Pol II |
|
sgGFP-neo fusion protein |
20µg |

sgGFP
and sgBFP Cloning Vectors
In order
to facilitate the use of AFPs® as fluorescent tags, a panoply
of fusion vectors are available. The pQBI25/50-fPA vectors contain short
cloning sites at the N- and C-termini of the AFPs®, to
allow the cloning of exogenous coding sequences (by PCR) with minimal
additions. Three series of vectors, pQBI25/50-fN 1,2,3, pQBI25/50-fA 1,2,3
and pQBI25/50-fC 1,2,3, have complete Multiple Cloning Sites (MCS) in
all three open reading frames, at the N- or C-terminus of the AFPs®
coding region. These three series of vectors also have a peptide linker
placed between the AFP, and the MCS to encourage independent folding of
the two protein moities without hindrance. The fA series of vectors contain
"Kozak" optimized initiation codons for optimal expression, whereas the
fN series of vectors have no initiation codon, allowing the use of the
endogenous sequences of the fusion protein. All of these vectors have
been designed as functional cassettes, permitting the isolation of the
CMV promoter region, AFPs® coding sequence, the polyadenylation
signal sequence, or any combination thereof. Each vector also contains
the SV40 neo cassette for biochemical selection of transformed cells.
sgGFP
Cloning Vectors
| Fusion
Sites |
| Cat.
No. |
Vector |
AFP |
Promoter |
N
C MCS |
Linker |
Comments |
Size |
| AFP2210 |
pQBI25-fPA |
sgGFP |
CMV |
Y Y |
|
Unique N- and
C-terminus restriction
sites for minimally
cloning PCR amplimers. |
20µg |
| AFP2211 |
pQBI25-fN1 |
sgGFP |
CMV |
Y Y N-Term |
Y |
Requires functional
ATG codon |
20µg |
| AFP2212 |
-fN2 |
sgGFP |
CMV |
Y Y N-Term |
Y |
Requires functional
ATG codon |
20µg |
| AFP2213 |
-fN3 |
sgGFP |
CMV |
Y Y N-Term |
Y |
Requires functional
ATG codon |
20µg |
| AFP2214 |
fN1 fN2 fN3 |
|
|
|
|
20µg of
each of the 3
reading frames |
20µg ea |
| AFP2221 |
pQBI25-fA1 |
sgGFP |
CMV |
Y Y N-Term |
Y |
|
20µg |
| AFP2222 |
-fA2 |
sgGFP |
CMV |
Y Y N-Term |
Y |
|
20µg |
| AFP2223 |
-fA3 |
sgGFP |
CMV |
Y Y N-Term |
Y |
|
20µg |
| AFP2224 |
fA1 fA2 fA3 |
|
|
|
|
20µg of
each of the 3
reading frames |
20µg ea |
| AFP2231 |
pQBI25-fC1, |
sgGFP |
CMV |
Y Y C-Term |
Y |
|
20µg |
| AFP2232 |
-fC2 |
sgGFP |
CMV |
Y Y C-Term |
Y |
|
20µg |
| AFP2233 |
-fC3 |
sgGFP |
CMV |
Y Y C-Term |
Y |
|
20µg |
| AFP2234 |
fC1 fC2 fC3 |
|
|
|
|
20µg of
each of the 3
reading frames |
20µg ea |
sgBFP
Cloning Vectors
| Fusion Sites |
| Cat.
No. |
Vector |
AFP |
Promoter |
N
C MCS |
Linker |
Comments |
Size |
| AFP2110 |
pQBI50-fPA |
sgBFP |
CMV |
Y Y |
|
Unique N- and
C-terminus restriction
sites for minimally cloning
PCR amplimers |
20µg |
| AFP2111 |
pQBI50-fN1 |
sgBFP |
CMV |
Y Y N-Term |
Y |
Requires functional
ATG codon |
20µg |
| AFP2112 |
-fN2 |
sgBFP |
CMV |
Y Y N-Term |
Y |
Requires functional
ATG codon |
20µg |
| AFP2113 |
-fN3 |
sgBFP |
CMV |
Y Y N-Term |
Y |
Requires functional
ATG codon |
20µg |
| AFP2114 |
fN1 fN2 fN3 |
|
|
  |
|
20µg of
each of the 3
reading frames |
20µg ea |
| AFP2121 |
pQBI50-fA1 |
sgBFP |
CMV |
Y Y N-Term |
Y |
|
20µg |
| AFP2122 |
-fA2 |
sgBFP |
CMV |
Y Y N-Term |
Y |
|
20µg |
| AFP2123 |
-fA3 |
sgBFP |
CMV |
Y Y N-Term |
Y |
|
20µg |
| AFP2124 |
fA1 fA2 fA3 |
|
|
|
|
20µg of
each of the 3
reading frames |
20µg ea |
| AFP2131 |
pQBI50-fC1 |
sgBFP |
CMV |
Y Y C-Term |
Y |
|
20µg |
| AFP2132 |
-fC2 |
sgBFP |
CMV |
Y Y C-Term |
Y |
|
20µg |
| AFP2133 |
-fC3 |
sgBFP |
CMV |
Y Y C-Term |
Y |
|
20µg |
| AFP2134 |
fC1 fC2 fC3 |
|
|
|
|
20µg of
each of the 3
reading frames |
20µg ea |

Subcellular
Localization Vectors
We offer
a number of sgGFP and sgBFP fusion vectors producing
proteins that localize to various subcellular regions.
- Increases
the sensitivity of detection
- Facilitates
double labeling experiments
- Enhances
the stability of the fluorescence when ethanol-based fixatives are used
| AFPs®
Localized Blue Fluorescene |
| Cat.
No. |
Vector |
Localization |
Description |
Promoter |
Size |
| AFP3101 |
pQBI-B23BFP |
Nucleolus |
Human B23-BFP |
CMV |
20µg |
| AFP3104 |
pQBI-revBFP |
Nucleolus |
HIV-1 rev-BFP |
CMV |
20µg |
|
AFPs® Localized Green Fluorescence |
| Cat.
No. |
Vector |
Localization |
Description |
Promoter |
Size |
| AFP3201 |
pQBI-B23sgGFP |
Nucleolus |
HumanB23-GFP |
CMV |
20µg |
| AFP3202 |
pQBI-tatGFP |
Nucleolus/Nucleus |
tat-GFP |
CMV |
20µg |
| AFP3203 |
pQBI-nefGFP |
Golgi, etc. |
nef-GFP |
CMV |
20µg |
| AFP3207 |
pQBI-LTRgagGFP
(rev-dependent) |
Cytoplasmic |
gag-GFP
(rev-dependent) |
HIV LTR |
20µg |

AIDS Research
Tools: AFP® Fusion Proteins
- Generates
fully bi-functional, localized, HIV-AFP fusion proteins
- Gag-GFP,
dependent on expression of functional rev-protein in the same cell,
serves as a rapid and sensitive indicator of HIV infection
- M10BLrev-AFP
constructs localize to the nucleolus; M10BL defective
| Cat.
No. |
Vector |
Localization |
Description |
Promoter |
Size |
| AFP3104 |
pQBI-revBFP |
Nucleolus/Cytoplasm
|
HIV-1 rev-BFP
|
CMV |
20µg |
| AFP3114 |
pQBI-LTRrevBFP
|
Nucleolus/Cytoplasm
|
HIV-1 rev-BFP
|
HIV LTR |
20µg |
| AFP3115 |
pQBI-LTRm10-BFP
|
Nucleolus |
m10BLrev-BFP |
HIV LTR |
20µg |
| AFP3202 |
pQBI-tatGFP |
Nucleolus/Nucleus
|
tat-GFP |
CMV |
20µg |
| AFP3203 |
pQBI-nefGFP |
Membrane associated
(Golgi, Endosomes etc) |
nef-GFP |
CMV |
20µg |
| AFP3205 |
pQBI-m10-GFP |
Nucleolus |
m10BLrev-GFP |
CMV |
20µg |
| AFP3206 |
pQBI-vprGFP |
Nucleolus/Nuclear
membrane |
vpr-GFP |
CMV |
20µg |
| AFP3207 |
pQBI-LTRgag-GFP
|
Cytoplasm |
gag-GFP |
HIV LTR
(Expression is
rev-dependent) |
20µg |


Anti-GFP
Antibodies
We offer
two monoclonal antibodies (mAb) for the detection of all of its GFPs.
Anti-GFP mAbs are purified from the supernatant of mouse hybridomas. Both
antibodies are highly specific for AFPs® and recognize
GFP/BFP and all other variants.
The 11E5
mAb is ideal for detection of GFP and GFP-fusion proteins in Western analyses.
Use of mAb 11E5 allows detection of as little as 10 ng of GFP using colorimetric
methods, and will detect picogram quantities with chemiluminescent detection
assays. Performing Western blots with the 11E5 mAb allows confirmation
that GFP and GFP-fusion proteins are being expressed and are of the expected
molecular weight.
The 3E6 mAb
is used for immunoprecipitation, immunocytochemistry, and ELISA assays.
The 3E6 is an IgG2a antibody, allowing purification of GFP and GFP-fusion
proteins with either protein A or protein G.
Both antibodies
are highly specific for GFPs in both bacterial and mammalian cell extracts,
providing clean purifications and strong clean signals.
Storage
-80°C

| Cat.
No. |
Product |
Applications |
Quantity |
| AFP 5001 |
Anti-GFP mAb11E5 |
Western, ELISA |
150µg |
| AFP 5002 |
Anti-GFP mAb 3E6 |
Immunoprecipitation,
Immunocytochemistry ELISA |
150µg |

Recombiant
Proteins
Recombinat
SuperGlo GFP and SuperGlo BFP can be used as
standards to calculate the level of expression and correlate it to the
relative fluorescence intensity.
Storage
-20°C
| Cat.
No. |
Product |
Description |
Quantity |
| AFP 5201 |
rGFP Protein |
Purified recombinant
sgGFP |
25µg |
| AFP 5202 |
rGFP Protein |
Purified recombinant
sgGFP |
100µg |
| AFP 5101 |
rBFP Protein |
Purified recombinant
sgBFP |
25µg |
| AFP 5102 |
rBFP Protein |
Purified recombinant
sgBFP |
100µg |

|